A BLOOD TEST THAT can predict with 90 percent accuracy if a healthy person will develop mild cognitive impairment (MCI) or Alzheimer’s disease within three years
A BLOOD TEST THAT can predict with 90 percent accuracy if a healthy person will develop mild cognitive impairment (MCI) or Alzheimer’s disease within three years has been discovered and validated by researchers at Georgetown and six other institutions.
The study team explains in the April issue of Nature Medicine (the paper was published online today) how they discovered and then validated a set of 10 lipid biomarkers in the blood that predict both conditions.
The discovery heralds the possible development of earlier treatment options for Alzheimer’s, when therapy could be more effective at slowing or even preventing onset of the disease.
“Our novel blood test offers the potential to identify people at risk for progressive cognitive decline and can change how patients, their families and treating physicians plan for and manage the disorder,” says the study’s corresponding author, Dr. Howard J. Federoff, executive vice president of health sciences at Georgetown University Medical Center.
There is currently no cure or effective treatment for Alzheimer’s disease, which, according to the World Health Organization, is expected to double every 20 years worldwide – from 35.6 million individuals in 2010 to 115.4 million by 2050.
Federoff, also a professor of neurology, explains there have been many efforts to develop drugs to slow or reverse the progression of Alzheimer’s disease, but all of them have failed. He says one reason may be the drugs were evaluated too late in the disease process.
“The preclinical state of the disease offers a window of opportunity for timely disease-modifying intervention, and biomarkers defining this asymptomatic period are critical for successful development and application of these therapeutics,” says Federoff.
‘MAJOR STEP FORWARD’
“The lipid panel was able to distinguish with 90 percent accuracy these two distinct groups – cognitively normal participants who would progress to MCI or AD within two to three years, and those who would remain normal in the near future,” says Federoff, who also serves as executive dean of the School of Medicine.
Researchers say the panel reveals changes in the breakdown of neural cell membranes resulting in 10 identifiable lipids, or metabolites, circulating in the blood. In particular, two of the 10 metabolites have strong links to the neuropathology of Alzheimer’s.
“We consider our results a major step toward the commercialization of a preclinical disease biomarker test that could be useful for large-scale screening to identify at-risk individuals,” Federoff concludes. “We’re intending to design a clinical trial where we’ll use this panel to identify people at high risk for Alzheimer’s to test a therapeutic agent that might delay or prevent the emergence of the disease.”
The Latest on: New blood test
[google_news title=”” keyword=”new blood test” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: New blood test
- Researchers develop 'game-changing' blood test for stroke detectionon May 18, 2024 at 5:08 pm
Stroke is the leading cause of disability worldwide and the second leading cause of death, but the right early intervention can prevent severe consequences. Scientists developed a new test by ...
- New blood test may detect 19 cancers 7 years before symptoms showon May 17, 2024 at 5:00 pm
A blood test detecting signs of 19 cancers seven years before symptoms ... optimism about the potential for preventing cancer through targeted drugs, thanks to new research findings. This research ...
- Blood Test Could Detect Cancer Up To Seven Years Earlieron May 17, 2024 at 7:21 am
A blood test to analyze proteins could detect cancer up to seven years before it is currently diagnosed, according to new research.
- New blood test for strokes could help tackle a $2 trillion problem, researchers sayon May 17, 2024 at 5:02 am
A new blood test can quickly detect a particularly severe type of stroke, according to new research published Friday, dramatically improving patients’ ...
- New blood test for stroke detection combines blood-based biomarkers with a clinical scoreon May 17, 2024 at 5:00 am
Stroke is the leading cause of disability worldwide and the second leading cause of death, but the right early intervention can prevent severe consequences. A new study led by investigators from ...
- New cancer-detecting blood test now available at University Hospitalson May 16, 2024 at 2:42 pm
The GRAIL Galleri test can screen for 50 different types of cancer. However, it should be used in addition to recommended cancer screenings.
- Blood test could detect preeclampsia in first trimester, LabCorp reportson May 15, 2024 at 7:53 am
Preeclampsia can be a life-threatening complication of pregnancy, but a new blood test can help predict a woman's risk for the condition while she is in her first trimester, the test's maker said ...
- New Blood Test Could Help Spot Preeclampsia in First Trimesteron May 15, 2024 at 5:21 am
Preeclampsia can be a life-threatening complication of pregnancy, but a new blood test can help predict a woman's risk for the condition while ...
- New screening tool can identify preeclampsia risk sooner, test maker sayson May 15, 2024 at 3:00 am
A new blood test can be performed in a pregnant person’s first trimester to help assess their risk of developing preeclampsia, a potentially life-threatening pregnancy complication.
- New screening tool can identify preeclampsia risk sooner, test maker sayson May 15, 2024 at 3:00 am
A new blood test can be performed in a pregnant person’s first trimester to help assess their risk of developing preeclampsia, a potentially life-threatening pregnancy complication. It’s the ...
via Bing News